about
Improvement in kidney transplantation in the Balkans after the Istanbul Declaration: where do we stand today?Editorial policies and background in editing Macedonian Medical Review and BANTAO journal.What Should be the Appropriate Referral to the Nephrologists - Do we have the Data?Balkan endemic nephropathy: a still unsolved puzzle.Application of Proteomic Analysis to Renal Disease in the Clinic.Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of DiseaseMulticentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Clinical practice guideline on diagnosis and treatment of hyponatraemia.Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP)Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.Diagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesImplementation of proteomic biomarkers: making it work.Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentreInconsistency of reported uremic toxin concentrations.Low turn-over bone disease in patients with chronic renal disease.Symmetric dimethyl arginine and N-acetyl-β-D-glucosaminidase lysozimuria of proximal renal tubules as a target for nephrotoxicity in patients with rheumatoid arthritis treated with disease modifying antirheumatic drugs.The role of EUTox in uremic toxin research.Phosphate metabolism in chronic kidney disease: from pathophysiology to clinical management.Conservative treatment of the uremic syndrome.The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.Acute fulminant hepatatis in kidney transplant recipient after repeated sevoflurane anesthesia--a case report and literature review.What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients.European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.Protocol for performing nephrological activity in the Republic of Macedonia.The improvement in kidney transplant program in R. Macedonia--what are the clues?Current status of transplantation and organ donation in the Balkans--could it be improved through the South-eastern Europe Health Network (SEEHN) initiative?South East European Health Network Initiative for Organ Donation and Transplantation.Advances in pharmacotherapy for hyperphosphatemia in renal disease.Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations.Hypomagnesemia and cause-specific mortality in hemodialysis patients: 5-year follow-up analysis.Successful Kidney Transplantation in a Patient with Multiple Perioperative Renal Transplant Complications. Case Report.The Effect of Treatment on Short-Term Outcomes in Elderly Patients with Acute Kidney Injury.The 20th anniversary of BANTAO (Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs).The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis.
P50
Q26769900-E4B62C0C-05E5-427E-B6AB-49106AE9040DQ30487670-2A70199C-80F0-4BE7-919F-1D23EB1F255CQ31144516-4E763ECA-446E-4738-A39D-AFC5D4960183Q33346201-7FEECF69-68E7-4544-BBD7-E620E08E019AQ33575004-D5A69D90-12C5-47C2-A955-A8A5C7521B58Q33597457-040F6E70-76D5-4FC4-B3D3-2C1F491484B4Q33985444-8875A404-7348-489B-A272-F6B9CD74AEECQ34406779-54ACB419-B94A-441D-B6D1-2FB9E512D232Q35245052-B8796D96-97B1-4CF3-8E21-A34562F85D4FQ35573682-BA297EAC-56DB-4C6C-B863-EEE638216001Q35712111-25C4DB52-11C2-4B75-879B-F555DE71DAF3Q35903097-76CE06AB-B713-49D1-A5CA-40CB0CDF10F7Q36297774-83C183D0-4091-46C9-BCA0-7DD82B2A4B19Q36670632-B3C30964-D042-4172-AABB-FDAD2B2FA23FQ36890915-A8A2AB78-2555-4A3F-8903-4A2F94A5CDDCQ37301138-8D91EE03-24BB-4ED9-8133-F213E6FD2E9EQ37455123-49BD7635-F848-42C9-8479-7E88019F2752Q37587267-F95D11EB-A4B7-4D1E-8276-CB8FC3E980A4Q37587283-5A64F0C4-D02D-4919-9E75-D865CAEB2F18Q37587339-B3D61922-08E1-4A45-9BAD-54172C0A3F02Q37734160-B94BD090-7E60-4FA1-97BC-2D9E11CA8EE5Q37786856-3FE03DD4-1D39-4AB5-BC2B-EE44D2B74673Q37871572-19053320-A286-468F-B2E2-4290A410B7A4Q38120857-D9BCC5C7-3CA5-4FE5-A149-11E8C9AABA09Q38161821-E59CB9A5-CFD2-40D2-A2A2-D0FA08AD099AQ38219038-B5242298-53F8-461A-8C40-96304A893E3CQ38227695-2E792565-0C02-489E-9C3A-BC6F64B5478FQ38286979-99FDE76A-DCD6-4E32-B8DD-A8690129C87FQ38402701-3E98846B-875B-4BC1-86A0-AE70976DC6A4Q38417078-521EA47C-F4D6-4C3A-8A6A-C7371992A4ACQ38543092-295FE6B4-A5BF-48C2-9380-47726819CF15Q38587575-DAC84D94-3355-49CA-90FB-96C15579CE23Q38613296-CA2F9556-1EBF-4D7E-A361-85118906A222Q38791111-6586C664-3936-49BA-A1D9-8087C77DF2C9Q38904252-A7094325-CE4C-4C1C-A515-8CF176514102Q40122870-AC897E5A-1CAE-4E94-A9F9-26B915EF800EQ40437277-551BA146-3237-4062-93DC-9095C9684DA4Q41464859-024D4767-C6FD-439E-9A44-A103F8FB82F0Q41877859-B7E217C3-7AFA-4B56-AD6E-CD35076BF7A8Q42685203-6971E75F-4C52-49BC-A81E-4239ECC4B444
P50
name
Goce Spasovski
@ast
Goce Spasovski
@en
Goce Spasovski
@es
Goce Spasovski
@nl
type
label
Goce Spasovski
@ast
Goce Spasovski
@en
Goce Spasovski
@es
Goce Spasovski
@nl
prefLabel
Goce Spasovski
@ast
Goce Spasovski
@en
Goce Spasovski
@es
Goce Spasovski
@nl